OraSure Technologies, Inc. (OSUR)

NASDAQ: OSUR · IEX Real-Time Price · USD
4.850
-0.070 (-1.42%)
At close: May 24, 2024, 4:00 PM
4.860
+0.010 (0.21%)
Pre-market: May 28, 2024, 7:00 AM EDT
-1.42%
Market Cap 358.70M
Revenue (ttm) 304.64M
Net Income (ttm) 22.85M
Shares Out 73.96M
EPS (ttm) 0.30
PE Ratio 16.17
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 507,809
Open 4.910
Previous Close 4.920
Day's Range 4.850 - 4.850
52-Week Range 4.380 - 8.450
Beta 0.23
Analysts Buy
Price Target 6.63 (+36.7%)
Earnings Date May 8, 2024

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection d... [Read more]

Sector Healthcare
IPO Date Nov 12, 1986
Employees 638
Stock Exchange NASDAQ
Ticker Symbol OSUR
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for OSUR stock is "Buy." The 12-month stock price forecast is $6.63, which is an increase of 36.70% from the latest price.

Price Target
$6.63
(36.70% upside)
Analyst Consensus: Buy
Stock Forecasts

News

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certai...

5 weeks ago - GlobeNewsWire

NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board

SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced ...

2 months ago - Business Wire

OraSure Reports Q4 ‘23 Revenue of $75.9 Million

Q4 GAAP EPS of $0.27 ; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 E nters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics D...

3 months ago - GlobeNewsWire

OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th

BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certai...

3 months ago - GlobeNewsWire

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

The relationship expands OraSure's innovation pipeline with access to a broad portfolio of key Sapphiros products in development.

5 months ago - GlobeNewsWire

OraSure to Participate in Upcoming Investor Conferences

BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory...

7 months ago - GlobeNewsWire

OraSure to Announce Third Quarter 2023 Financial Results and Host Earnings Call on November 7th

BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and certain...

7 months ago - GlobeNewsWire

OraSure Reports Q2 ‘23 Revenue of $85.4 Million; Core Revenue Grows 3% Year-over-Year

InteliSwab® test revenue of $47.5 million in Q2 Q2 Core revenue of $37.9 million grew 4% sequentially and 3% year-over-year Q2 GAAP EPS of $(0.07); Q2 Non-GAAP EPS of $0.09 Grew cash balance to $185.9...

10 months ago - GlobeNewsWire

OraSure Technologies Elects Robert McMahon to the Board of Directors

BETHLEHEM, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory...

11 months ago - GlobeNewsWire

Study Concludes Self-Sampling Using Colli-Pee® Device for HPV Screening Is Both Cost Effective and Could Improve Patient Access

BETHLEHEM, Pa., June 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling tech...

1 year ago - GlobeNewsWire

OraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core Growth

InteliSwab ® test revenue of $118.3 million in Q1, up 33% sequentially;  Company delivers cost savings and begins to taper InteliSwab ® test production and expenses

1 year ago - GlobeNewsWire

2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ET

BETHLEHEM, Pa., May 03, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2023 first quarter financial results and certain ...

1 year ago - GlobeNewsWire

OraSure Reports 4Q22 Record Revenue of $123.1 Million Growing 94% Year-Over-Year; Positions for Longer-Term Growth and Profitability

InteliSwab ® revenue of $88.9 million in Q4, up 12% sequentially; wins two new federal government contracts extending the tail on InteliSwab ® revenue

1 year ago - GlobeNewsWire

2022 Fourth Quarter Earnings Conference Call Tuesday, February 14, 2023, 5:00 p.m. ET

BETHLEHEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 fourth quarter financial results and certai...

1 year ago - GlobeNewsWire

OraSure Technologies Continues its Dedication to Ending the HIV Epidemic

Company to Ring Nasdaq Closing Bell in New York City in Observation of World AIDS Day Company to Ring Nasdaq Closing Bell in New York City in Observation of World AIDS Day

1 year ago - GlobeNewsWire

OraSure Technologies to Present at Stephens Annual Investment Conference

BETHLEHEM, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, microbiome laboratory and analytic...

1 year ago - GlobeNewsWire

OraSure Reports 3Q22 Record Revenue of $116.5 Million Growing 116% Year-Over-Year

InteliSwab® revenue of $79.6 million in Q3, up 85% sequentially; Company continues to expand test production capacity

1 year ago - GlobeNewsWire

OraSure Technologies Receives General Clearance for its ORAcollect®•Dx Device for Over-the Counter (OTC) Use from the U.S. Food and Drug Administration (FDA)

FDA Clearance Received Through Partnership with Grifols to Support Screening for Risk of Alpha1- Antripsyn Deficiency (Alpha-1) in U.S. Adult Population

1 year ago - GlobeNewsWire

InteliSwab® COVID-19 Rapid Test Now Available in Amazon's Online Store

BETHLEHEM, Pa., Nov. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced ...

1 year ago - GlobeNewsWire

2022 Third Quarter Earnings Conference Call Tuesday, November 8, 2022, 5:00 p.m. ET

BETHLEHEM, Pa., Nov. 01, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 third quarter financial results and certain...

1 year ago - GlobeNewsWire

OraSure Technologies Receives $8.6 Million BARDA Contract to Develop 2nd Generation Ebola Test

BETHLEHEM, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced...

1 year ago - GlobeNewsWire

OraSure Wins Contract to Supply “Together Take Me Home,” HIV Self-Testing Initiative Sponsored by the Centers for Disease Control and Prevention

The effort promotes HIV testing and awareness in populations disproportionately affected by HIV The effort promotes HIV testing and awareness in populations disproportionately affected by HIV

1 year ago - GlobeNewsWire

OraSure Partners with Mars Petcare in One of the Largest Ever Microbiome Studies to Evaluate Pet Health

BETHLEHEM, Pa., Sept. 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced...

1 year ago - GlobeNewsWire

OraSure Reports 2Q22 Record Revenue of $80.2 Million Growing 39% Year-Over-Year

InteliSwab ® revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production

1 year ago - GlobeNewsWire

OraSure Technologies to Hold 2022 Second Quarter Earnings Conference Call Tuesday, August 9, 2022, 5:00 p.m. ET

BETHLEHEM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and certai...

1 year ago - GlobeNewsWire